Correction to: Adv Ther 10.1007/s12325-019-00940-7
Unfortunately, the mean difference in change from baseline ACT was incorrectly reported in the abstract as 19.0 vs. 20.8 instead of 18.9 vs. 20.7
The original version of this article was revised.
. 2019 Jun 9;36(7):1770. doi: 10.1007/s12325-019-00975-w
Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®
Jörgen Syk
1,2,3, Ines Vinge
4, Mikael Sörberg
5, Mikko Vahteristo
6, Paula Rytilä
7,✉
Jörgen Syk
1Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
2Academic Primary Health Care Centre, Stockholm, Sweden
3Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
Find articles by Jörgen Syk
Ines Vinge
4Asthma-Allergy-Lung Department, Lidingö Hospital, Lidingö, Sweden
Find articles by Ines Vinge
Mikko Vahteristo
6Orion Corporation, Orion Pharma, Kuopio, Finland
Find articles by Mikko Vahteristo
1Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
2Academic Primary Health Care Centre, Stockholm, Sweden
3Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
4Asthma-Allergy-Lung Department, Lidingö Hospital, Lidingö, Sweden
5Orion Pharma, Danderyd, Sweden
6Orion Corporation, Orion Pharma, Kuopio, Finland
7Orion Corporation, Orion Pharma, Espoo, Finland
✉
Corresponding author.
Received 2019 Feb 22; Issue date 2019.
© The Author(s) 2019
Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
PMCID: PMC6824391 PMID: 31179515
This corrects the article "A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®" on page 1756.